|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
37,960,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile iTeos Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of a differentiated immuno-oncology therapeutics for patients. Co.'s product candidate, inupadenant, is designed as a selective small molecule antagonist of the adenosine A2a receptor, in the adenosine pathway, a main driver of immunosuppression in the tumor microenvironment across a range of tumors. Co.'s main antibody product candidate, EOS-448, is an antagonist of T-cell immunoreceptor with Ig and ITIM domains, an immune checkpoint with multiple mechanisms of action leading to immunosuppression.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
4,958,978 |
4,958,978 |
4,963,978 |
4,968,978 |
Total Buy Value |
$38,685,562 |
$38,685,562 |
$38,724,197 |
$38,766,047 |
Total People Bought |
1 |
1 |
2 |
2 |
Total Buy Transactions |
2 |
2 |
3 |
4 |
Total Shares Sold |
2,668,407 |
2,668,407 |
2,668,407 |
3,018,407 |
Total Sell Value |
$22,281,230 |
$22,281,230 |
$22,281,230 |
$27,973,903 |
Total People Sold |
5 |
5 |
5 |
6 |
Total Sell Transactions |
16 |
16 |
16 |
17 |
End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Detheux Michel |
Chief Executive Officer |
|
2025-06-10 |
4 |
OE |
$4.30 |
$593,013 |
I/I |
137,910 |
94,027 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-10 |
4 |
OE |
$4.30 |
$113,520 |
D/D |
26,400 |
153,903 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-10 |
4 |
AS |
$10.02 |
$439,708 |
I/I |
(43,883) |
0 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-10 |
4 |
AS |
$10.02 |
$84,168 |
D/D |
(8,400) |
135,903 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-09 |
4 |
AS |
$10.03 |
$440,136 |
I/I |
(43,882) |
0 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-09 |
4 |
OE |
$4.30 |
$188,693 |
I/I |
43,882 |
43,882 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-09 |
4 |
AS |
$10.03 |
$84,252 |
D/D |
(8,400) |
135,903 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-09 |
4 |
OE |
$4.30 |
$36,120 |
D/D |
8,400 |
144,303 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-06 |
4 |
AS |
$10.21 |
$448,035 |
I/I |
(43,882) |
0 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-06 |
4 |
OE |
$4.30 |
$188,693 |
I/I |
43,882 |
43,882 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-06 |
4 |
AS |
$10.21 |
$85,764 |
D/D |
(8,400) |
135,903 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-06 |
4 |
OE |
$4.30 |
$36,120 |
D/D |
8,400 |
144,303 |
|
- |
|
Hallal David |
|
|
2025-06-06 |
4 |
AS |
$10.24 |
$391,455 |
D/D |
(38,228) |
0 |
|
- |
|
Hallal David |
|
|
2025-06-06 |
4 |
OE |
$4.30 |
$164,380 |
D/D |
38,228 |
38,228 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-05 |
4 |
AS |
$10.15 |
$445,402 |
I/I |
(43,882) |
0 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-05 |
4 |
OE |
$4.30 |
$188,693 |
I/I |
43,882 |
43,882 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-05 |
4 |
AS |
$10.15 |
$85,260 |
D/D |
(8,400) |
135,903 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-05 |
4 |
OE |
$4.30 |
$36,120 |
D/D |
8,400 |
144,303 |
|
- |
|
Hallal David |
|
|
2025-06-05 |
4 |
AS |
$10.15 |
$388,004 |
D/D |
(38,227) |
0 |
|
- |
|
Hallal David |
|
|
2025-06-05 |
4 |
OE |
$4.30 |
$164,376 |
D/D |
38,227 |
38,227 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-04 |
4 |
AS |
$10.10 |
$443,218 |
I/I |
(43,883) |
0 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-04 |
4 |
OE |
$4.30 |
$188,697 |
I/I |
43,883 |
43,883 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-04 |
4 |
AS |
$10.10 |
$84,840 |
D/D |
(8,400) |
135,903 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2025-06-04 |
4 |
OE |
$4.30 |
$36,120 |
D/D |
8,400 |
144,303 |
|
- |
|
Hallal David |
|
|
2025-06-04 |
4 |
AS |
$10.07 |
$384,946 |
D/D |
(38,227) |
0 |
|
- |
|
268 Records found
|
|
Page 1 of 11 |
|
|